Morrisons Chesty Cough (Guaifenesin Bp)

Guaifenesin works by increasing the volume of secretions in the respiratory tract while reducing their viscosity. This action thins the mucus, enhances ciliary movement, and promotes more efficient clearance of mucus from the airways, which helps alleviate congestion.

The appropriate dose is determined by a prescriber based on the patient’s age, weight, and clinical condition. Healthcare professionals follow local labeling guidelines and adjust the regimen to achieve optimal symptom relief while minimizing adverse effects.

Safety data for guaifenesin in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Morrisons Chesty Cough uses guaifenesin, which primarily thins mucus. Other expectorants such as bromhexine act by breaking down mucopolysaccharide bonds, while mucolytic agents like acetylcysteine have antioxidant properties. Choice of agent depends on the clinical scenario, patient tolerance, and physician preference.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure the packaging is tightly closed to maintain product stability.

The medication is taken orally with a full glass of water. It can be taken with or without food, but adequate hydration is recommended to support the mucus‑thinning effect. Follow the dosing instructions provided by the prescriber.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome, and persistent vomiting. Patients should seek immediate medical attention if they experience difficulty breathing, swelling of the face or throat, or a widespread rash.

Individuals with known hypersensitivity to guaifenesin or any excipients in the formulation should avoid this product. It is also contraindicated in patients for whom an expectorant is not appropriate, such as those with non‑productive coughs or certain respiratory conditions without medical advice.